Danielle Campbell - LIFE Old VP Resource
Insider
Danielle Campbell is VP Resource of LIFE Old
| Phone | 858 731 8389 |
| Web | https://www.atyrpharma.com |
LIFE Old Management Efficiency
The company has return on total asset (ROA) of (0.2937) % which means that it has lost $0.2937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5561) %, meaning that it created substantial loss on money invested by shareholders. LIFE Old's management efficiency ratios could be used to measure how well LIFE Old manages its routine affairs as well as how well it operates its assets and liabilities.LIFE Old currently holds 15.1 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. LIFE Old has a current ratio of 9.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about LIFE Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Liean MS | Acumen Pharmaceuticals | N/A | |
| Alexandra HughesWilson | Mereo BioPharma Group | 54 | |
| MBBS MD | Mereo BioPharma Group | 54 | |
| Siew MS | Acumen Pharmaceuticals | N/A | |
| MD MBA | Amylyx Pharmaceuticals | 63 | |
| Demetrios MD | Inozyme Pharma | N/A | |
| Russell MS | Acumen Pharmaceuticals | 67 | |
| Julie MBA | Day One Biopharmaceuticals | 42 | |
| Eric MD | Acumen Pharmaceuticals | 69 | |
| Henric Bjarke | Inozyme Pharma | 57 | |
| Reinhard Kandera | Hookipa Pharma | 55 | |
| Nathalie Riebel | PDS Biotechnology Corp | N/A | |
| MBA MBA | Mereo BioPharma Group | 67 | |
| John Lewicki | Mereo BioPharma Group | 73 | |
| Mike Preigh | Day One Biopharmaceuticals | N/A | |
| Margaret MBA | Amylyx Pharmaceuticals | 59 | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Klaus Orlinger | Hookipa Pharma | 47 | |
| Christine MBA | Hookipa Pharma | 59 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| Christine CPA | Mereo BioPharma Group | 44 | |
Management Performance
| Return On Equity | -0.56 | |||
| Return On Asset | -0.29 |
LIFE Old Leadership Team
Elected by the shareholders, the LIFE Old's board of directors comprises two types of representatives: LIFE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LIFE. The board's role is to monitor LIFE Old's management team and ensure that shareholders' interests are well served. LIFE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LIFE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Danielle Campbell, VP Resource | ||
| Melissa Ashlock, Vice President - External Scientific Alliances and Human Genetics | ||
| MS MD, CEO President | ||
| XiangLei Yang, Founder | ||
| Ying Buechler, Executive Manufacturing | ||
| Jill Broadfoot, Chief Officer | ||
| David King, Senior Vice President - Research | ||
| Ashlee Dunston, Director Communications | ||
| Peter Villiger, Vice Development | ||
| Leslie Nangle, Vice Research | ||
| Nancy Krueger, General Secretary |
LIFE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LIFE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.56 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (70.79) % | |||
| Current Valuation | 55.05 M | |||
| Shares Outstanding | 69.01 M | |||
| Shares Owned By Insiders | 2.61 % | |||
| Shares Owned By Institutions | 61.69 % | |||
| Number Of Shares Shorted | 343.41 K | |||
| Price To Earning | (2.19) X | |||
| Price To Book | 1.30 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in LIFE Stock
If you are still planning to invest in LIFE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LIFE Old's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |